Phase II Study of Intrathecal Ziconotide for the Treatment of Neuropathic Pain in Patients With Cancer
Phase of Trial: Phase II
Latest Information Update: 15 Feb 2018
At a glance
- Drugs Ziconotide (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- Acronyms ZIDON
- 15 Feb 2018 Status changed from active, no longer recruiting to completed.
- 28 Mar 2017 Planned End Date changed from 1 Jul 2017 to 1 Jul 2018.
- 28 Mar 2017 Planned primary completion date changed from 1 Jul 2016 to 1 Sep 2017.